Evidence mapPaperPMID 41635977Full record

ArticleAdvanced healthcare materials2026

Nb

Zhi Zheng, Heyan Huang, Xiangru Chen, Jie Fu, Zhiwei Sun, Mengjuan Tao, Jianwei Mao, Fei Zhang, Zhou Wan, Yuan Li and 3 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Zhi ZhengDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Heyan HuangDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Xiangru ChenDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Jie FuDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Zhiwei SunDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Mengjuan TaoDepartment of Clinical Laboratory, Wuhan Center for Clinical Laboratory, Wuhan, Hubei, P. R. China.
Jianwei MaoDepartment of Hepatobiliary Surgery, Xiaogan Center Hospital, Xiaogan, Hubei, P. R. China.
Fei ZhangDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Zhou WanDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Yuan LiDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Dingan WuDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Chuchao ZhouDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.
Yanqing YangDepartment of Plastic Surgery, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan, Hubei, P. R. China.ORCID https://orcid.org/0009-0009-9162-5850

Funding

Hubei Provincial Central Guidance Local Science and Technology Development Project 2022BGE264Knowledge Innovation Project of Wuhan 2023020201020545Medical Science Research Project of Wuhan (WX23A05), Traditional Chinese Medicine Research Project of Wuhan WZ24A14Natural Science Foundation of Hubei Province 2025AFB975
6 · The paper itself

Abstract

Excessive and continuous production of reactive oxygen species (ROS) is a significant factor contributing to severe inflammation, bacterial infections, and poor angiogenesis, and it can also delay the healing of diabetic wounds. However, traditional clinical treatment methods are unable to effectively eliminate ROS. Herein, a dual ROS-scavenging platform that integrates multifunctional niobium carbide (Nb

Indexed as

Diabetes Mellitus, ExperimentalFree Radical ScavengersHydrogelsNiobiumReactive Oxygen SpeciesWound HealingAnimalsAnti-Bacterial AgentsCurcuminHumansMacrophagesMaleMiceMicroneedle Drug DeliveryRAW 264.7 CellsAnti-Bacterial AgentsCurcuminFree Radical ScavengersHydrogelsNiobiumniobium carbideReactive Oxygen Speciescurcumindiabetic wound healingmicroneedleniobium carbide nanosheetROS‐scavenging

Identifiers

PMID41635977
PMCPMC13088758

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.